Enveric Biosciences' CBD-Based Product Reduces Dermatitis Severity In Animal Study
Checkpoint Therapeutics CEO On Tapping Into A $25 Billion Cancer Treatment Market
SponsoredValeant Stock Moves Higher After FDA Approves Bowel Cleanser
Endocyte Shares Up More Than 100% In 2 Days, But Analyst Sees Even More Upside Possible
Cancer Treatment Recent News
Everything We Know About Merck's Keytruda
These Biotechs Are Getting Crushed Following Juno's Cancer Drug Hold
Here's Why OXiGENE Surged 65% Early Tuesday Morning
Trovagene Gains 3% On Favorable Mention In Medical Journal
Cellular Biomedicine's Stock Surges After Company Receives Strategic Investment
Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average
Vetr Crowd Sees Juno Therapeutics As A Five-Star Stock
What's Going On With Insys Therapeutics?